European Archives - Page 579 of 1232 - European Medical Journal

Huntingtin as a Presymptomatic Regulator of Alzheimer’s Disease

The identification of pathological elements that drive disease progression, so-called regulators, is essential when studying progressive diseases.

Updates in the Treatment of Gastroenterological Disorders

Digestive Disease Week (DDW) 2022 was held both in San Diego, California, USA, and virtually. The meeting featured cutting-edge research and education in the field of gastroenterology, of which eight treatment-related presentations are summarised in this article.

EMJ Neurology 10.1 Feature Image

Review of the European Academy of Neurology (EAN) 2022 Congress

THE CURTAIN OPENED on the 8th European Academy of Neurology (EAN) 2022 Congress on 25th June 2022 in Vienna, Austria, with EAN President Claudio Bassetti welcoming more than 8,000 neurologists from around the world.

EMJ Neurology 10.1 Feature Image

Implications of the First Ex Vivo Gene Therapy Approved for Treating Early-Onset Metachromatic Leukodystrophy

MLD is caused by an accumulation of sulfatides in various organs and predominantly the central nervous system (CNS). Patients have an initial period of normal development, then experience developmental delay or stagnation (Figure 1).

EMJ Neurology 10.1 Feature Image

EMJ Neurology 10.1 2022

Welcome to our latest issue of EMJ Neurology, our updates on the latest research and expert insights in the field. Just some of the featured articles include a review of adiposity and neurological disorders, an analysis of sex-related differences in stroke presentation, and a rare case of paediatric NMDAR encephalitis.

EMJ Gastroenterology 11 [Supplement 4] 2022

Digestive Disease Week (DDW) 2022 was held both in San Diego, California, USA, and virtually. The meeting featured cutting-edge research and education in the field of gastroenterology, of which eight treatment-related presentations are summarised in this article. Two presentations covered recent patient surveys.

EMJ

MRI Response Assessment in Patients with Glioblastoma Treated with Dendritic Cell-Based Immunotherapy

In glioblastoma (GB), patients’ reliable response assessment criteria are crucial in order to accurately compare the responsiveness of different therapies in clinical trials, and to differentiate between therapy-induced changes and true tumour progression.

EMJ Neurology 10.1 Feature Image

Highlights from EAN 2022

This year’s European Academy of Neurology (EAN) Congress offered a plethora of sessions in different areas of neurology.

EMJ

Brain Tumour-Related Epilepsy: Impact of Grading and Treatments in a Cohort of Molecularly Defined Lower-Grade Gliomas

Brain tumour-related epilepsy (BTRE) is associated with diffuse lower-grade gliomas (DLGG) in up to 70–90% of cases.

Einar August Høgestøl

EAN Congress Interview - Einar August Høgestøl

Einar August Høgestøl | Associate Professor, Department of Psychology, University of Oslo, Norway; Doctor-in-Training, Department of Neurology, Oslo University Hospital, Norway; 2022. Author of the Best Presentation in Basic Neurology at the European Academy of Neurology (EAN) Tournament for Neurologists in Training.